Binding of the antileukaemic drug L-asparaginase from escherichia coli to the plasma membrane of normal human mononuclear cells;Asociación de la droga antileucémica L-asparraginasa de escherichia col a la membrana plasmática de células mononucleares humanas normales

Sangre

Volumn 44, Issue 3, 1999, Pages 204-209

  Mercado Vianco, Luis ^b   Arenas Díaz, Gloria ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE VALPARAÍSO   (Chile)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BACTERIAL PROTEIN; DRUG CARRIER; MEMBRANE LIPID; MONOCLONAL ANTIBODY;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; ASCITES; CAPPING PHENOMENON; CELL MEMBRANE; CHEMICALLY INDUCED DISORDER; CONFOCAL MICROSCOPY; CROSS REACTION; DRUG EFFECT; ENZYMOLOGY; ERYTHROCYTE MEMBRANE; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MONOCYTE; MONONUCLEAR CELL; MOUSE; THROMBOEMBOLISM;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTINEOPLASTIC AGENTS; ASCITES; ASPARAGINASE; BACTERIAL PROTEINS; CELL MEMBRANE; CROSS REACTIONS; DRUG CARRIERS; ERYTHROCYTE MEMBRANE; ESCHERICHIA COLI; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MEMBRANE LIPIDS; MICE; MICROSCOPY, CONFOCAL; MONOCYTES; RECEPTOR AGGREGATION; THROMBOEMBOLISM;

EID: 0042259225     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Swain AL, Jalskólski M, Housset D, Mohana JK, Wlodawer A. Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy. Proc Natl Acad Sci USA 1993; 90: 1474-1478.
2. . Broome JD. Evidence that the L-asparaginase activity of guinea pig serum is responsible for its antilymphoma effects. Nature 1961; 91: 1114-1115.
3. Adamson RH, Fabro S. Antitumor activity and other biologic properties of L-asparaginase. Cancer Chemother Rep 1968, 52: 617-626.
4. Wriston Jr JC, Yelling TO. L-asparaginase: a review. Adv Enzymol 1973; 39: 185-248.
5. Kafkewitz D, Bendich A. The inhibition of lymphocyte mitogenesis by asparaginase: Astill unexplained phenomenon. Experimentia 1984; 40: 1173-1177.
6. Bartalena L, Martino E, Pacchiarotti A, Balzano S, Falcone M, Sica V et al. Effects of the antileukemic drug L-asparaginase on sex hormone-binding globulin: studies in vivo and in vitro. J Endocrinol Invest 1989; 12: 489-493.
7. Clausen N, Nielsen JH. Direct long-term effects of L-asparaginase on rat and human pancreatic islets. Pediat Res 1989; 26: 158-161.
8. Wriston JC Jr. Asparaginase. En: Methods in enzymology. Academic Press Inc 1985; 113: 608-618.
9. Rekharsky MV, Skya AZ, Lopatnev SV, Slozhenikia YB, Egorov AM, Galchenko GL. Simple industrial method for determination of activity of asparaginase and some other enzymes. J Biochem Biophy Methods 1986; 12: 247-249.
10. Haley EE, Fisher GA, Welch AD. The requirement for L-asparagine of mouse leukemia cells L5178Y in culture. Cancer Res 1961; 21: 532-536.
11. Kyriadis DA, Tsirka SE, Tsavaridis IK, Iliadis SN, Kortsaris AH. Antiproliferative activity of L-asparaginase of Tetrahymena pyriformis on human breast cancer cell lines. Mol Cell Biochem 1990; 96: 137-142.
12. Asselin BL, Lorenson MY, Whitin JC, Coppola DJ, Kende SA, Blakley RL et al. Measurement of serum L-asparaginase in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor. Cancer Res 1991; 51: 6568-6573.
13. Nakayama H, Hayashi T, Salata KF, Notkins AL. Flow cytometry to identify cell types to wich enzymes bind. Effect of lactic dehydrogenase virus on enzyme binding. J Biol Chem 1990; 265: 14355-14357.
14. Mesas JM, Gil JA, Martin JF. Characterization and parcial purification of L-asparaginase from Corynebacterium glutamicum. J General Microbiol 1990; 132: 515-519.
15. Boyum A. Separation of leukcoytes from blood and bone marrow. Scand J Clin Lab Invest 1968; 21 (Suppl 97): 77.
16. English D, Andersen BR. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinues gradient of ficoll-hypaque. J Immunol Methods 1974; 5: 249.
17. Dodge JT, Mitchell C, Hanahan D. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 100: 119.
18. Finean JB, Mitchell RH. Membrane structure. Elsevier/North Holland. Biomedical Press 1981; 112-116.
19. Cevenini R, Sambri V, Pileri S, Ratti G, La Placa M. Development of transplantable ascites tumours wich continuously produce polyclonal antibodies in pristane primed BALB/c mice immunized with bacterial antigens and complete Freund's adjuvant. J Immunol Methods 1991; 140: 111-118.
20. Lichtman JW. Microscopia confocal. Investigación y Ciencia 1994; 217: 20-25.
21. Laemmli UK. Cleavange of structural proteins during the assembly of head of bacteriophage T4. Nature (Lond) 1970; 227: 680-685.
22. Towbin H, Staehelin T, Gordon G. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets; procedure and some application. Proc Nat Acad Sci USA 1979; 76: 4350-4354.
23. Harlow E, Lane D. Antibodies: A laboratory manual. New York. Cold Spring Harbor Laboratory 1988; 509.
24. Gentili D, Zucchetti M, Conter D, Masera G, D'Incalci M. Determination of L-asparagine in biological samples in the presence of L-asparaginase. J Chromatogr B Biomed Appl 1994; 657: 47-52.
25. Roitt I, Brostoff J, Male D. Células que intervienen en la respuesta inmunitaria. En: Inmunología. Madrid Harcourt Brace de España S.A. 1997; 2,1-2,18.
26. Tsirka SE, Kyriakidis DA. In vitro alterations of L-asparaginase activity of Tetrahyhmena pyriformis by lipids. Mol Cell Biochem 1988; 83: 147-155.
27. Triantafillou DJ; Georgatsos JG, Kyriakidis DA. Purification and properties of a membrane-bound L-asparaginae of Tetrahymena pyriformis. Mol Cel Biocem 1988; 81: 43-51.
28. Mazzucconi MG, Gugliotta L, Leone G, Dragoni F, Belmonte MM, De Stefano V et al. Antithrombin III infusion suppreses the hypercoagulahle state in adult acute lymphoblastic leukaemia patients treated with a low dose of Eschericihia coli L-asparaginase. A GIMENA study. Blood Coagul. Fiorinolysis 1994; 5: 23-28.
29. Mitchell LG, Halton JM, Vegh PA, Barr RD, Venneri T, Pai KM et al. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol Oncol 1994; 16: 120-126.
30. Kravtzoff R, Desbois I, Lamagnere JP, Muh JP, Valat C, Chassaigne M et al. Improved pharmacodynamics of L-asparaginase loaded in human red blood cells. Eur J Clinic Pharm 1996; 49: 465-470.
31. Gaspar MM, Perezscler R, Cruz ME. Biological characterization of L-asparaginase liposomal formulations. Cancer Chemother Pharmacol 1996; 38: 373-377.